\
Onvansertib effectively targets the once “undruggable” KRAS-mutation present in 50% of colorectal cancerNew Podcast

Turning the Tide on Cancer

Investing in Cardiff Oncology to Provide New Treatment Options for Cancers with the Greatest Medical Need

Events

Cowen 41st Annual Health Care Conference
 March 2, 2021
 6:50am - 7:50am PST

Dr. Mark Erlander, chief executive officer of Cardiff Oncology, will participate in a GI Oncology and Pancreatic Cancer Panel discussion on Tuesday, March 2nd at 9:50 am ET.  The panel discussion is available for live viewing by conference attendees only.